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Abstract
Background: The formation of adhesions following abdominal surgery is a well known problem.
In previous studies we demonstrated the efficacy and safety of intraperitoneally applied
phospholipids in order to prevent adhesion formation. This study evaluates the influence of blood
on the efficacy of intraperitoneally applied phospholipids for prevention of adhesions.
Methods: In 40 Chinchilla rabbits adhesions were induced by median laparotomy, standardized
abrasion of the visceral and parietal peritoneum in defined areas of the ventral abdominal wall and
the caecum. The animals were randomly divided into four groups. They received either
phospholipids 3.0% or normal saline (NaCl 0,9%) (5 ml/kg body weight). In 50% of the rabbits we
simulated intraperitoneal bleeding by administration of blood (1,5 ml/kg body weight). The other
half served as control group. Ten days following the operation the animals were sacrificed and
adhesion formation was assessed by computer aided planimetry and histopathologic examination.
Results: The median adhesion surface area in the NaCl-group (n = 9) amounted to 68,72 mm2, in
the NaCl+Blood-group (n = 10) 147,68 mm2. In the Phospholipid (PhL)-group (n = 9) the median
adhesion surface area measured 9,35 mm2, in the PhL+Blood-group (n = 9) 11,95 mm2. The
phospholipid groups had a significantly smaller adhesion surface area (p < 0.05).
Conclusion: Again these results confirm the efficacy of phospholipids in the prevention of
adhesions in comparison to NaCl (p = 0,04). We also demonstrated the adhesion preventing effect
of phospholipids in the presence of intraperitoneal blood.
Background
Postoperative peritoneal adhesions are frequent and seri-
ous sequelae after abdominal surgery. They cause recur-
rent and chronic complaints and pain as well as female
infertility, and they increase the duration and complica-
tion rate of reoperations[1,2]. The incidence of postoper-
ative peritoneal adhesions and their related complications
are constantly rising parallel to increasing longevity and
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are the most frequent cause of intestinal obstruction,
account for 3% of all hospital admissions in general sur-
gery, and are responsible for about 30% of all cases of
female infertility. Intestinal obstruction as the most life
threatening adhesion-related disease is associated with
mortality rates of up to 15%[5,6]. Adhesions as almost
inevitable sequel after abdominal procedures are generat-
ing a rising clinical workload and need for substantial
health care expenditures [7-12].
Peritoneal lesions caused by abrasion, ischaemia, desicca-
tion, infection, thermal injury, and foreign bodies are the
origin of adhesions. Especially the presence of blood is an
initiating causepoint of adhesions. Traumatization leads
to a deposition of fibrin and fibrinous, potentially tempo-
rary, adhesions. Postoperatively, however, tissue plas-
minogen activator (t-PA) activity is reduced and
inflammatory cytokines (tumor necrosis factor (TNF),
Interleukin-1 (IL-1), Interleukin-6 (IL-6)) as well as plas-
minogen activator inhibitors (PAI-1, PAI-2) are elevated.
Due to the hereby decreased fibrinolytic activity in the
peritoneal cavity, the fibrin depositions are infiltrated by
granulocytes, monocytes, and fibroblasts followed by
ingrowth of capillaries, deposition of collagen, and
fibrous permanent adhesions[13].
The clinical consequences call for adjuvant means for pre-
vention and control of peritoneal adhesions. A plethora of
attempts have been made at prevention and control of
postoperative adhesion formation. All efforts directed at
the reduction of the surgical trauma by using laparoscopic
access and meticulous preparation however, could not
solve this problem[14,15]. With the pathogenesis in
mind, the idea to enhance the fibrinolytic activity by e.g.
urokinase or recombinant tissue plasminogen activator
(rtPA) was striking. But in the clinical routine the result
would be a possible disturbance of the delicate balance
between coagulation and fibrinolysis causing a postoper-
ative bleeding hazard[16].
Non-steroidal anti-inflammatory drugs and corticoster-
oids carry the risk of haemorrhage, ulcers with subsequent
bleeding, immunosuppression, and healing disorders.
Saline solutions are too rapidly absorbed and hydrofloat-
ation by macromolecular solutions like dextran show sig-
nificant adverse effects like fluid shifting, impairment of
liver function, even rare cases of dissiminated intravascu-
lar coagulation, and anaphylactic shock[15,17].
Phospholipids are a surfactant-like substance with excel-
lent release and lubricating properties that adsorb as an
oligolamellar lining to the mesothelium[18]. They offer
the possibility to cover the whole surface of the visceral
and parietal peritoneum by a small amount of fluid dur-
ing healing of the serosal defects. By acting as a liquid bar-
rier separating opposite areas of the peritoneum by a very
thin membrane-like film they proved to reduce adhesion
formation and reformation in different settings including
general peritonitis[19,20].
Experiments with different settings demonstrated a signif-
icant reduction of adhesion formation after single intraab-
dominal administration without any adverse effects [19-
22].
During operative procedures some degree of bleeding is
inevitable. This small amount of blood can induce adhe-
sions. Special barriers for prevention of adhesions in form
of patches are ineffective in the presence of blood [29-31].
In this study we evaluate the efficacy of phospholipids in
a bleeding model.
Methods
Animals and Anaesthesia
A total of 40 Chinchilla rabbits (mean body weight 2.9 ±
0.6 kg) were included in this study. The animals were kept
in single cages under standard laboratory conditions with
unrestricted access to a balanced pellet diet and water.
After adaptation, the rabbits were randomly assigned to
four different groups of equal numbers. The surgical pro-
cedures were performed under sterile conditions and gen-
eral anaesthesia by i.v. administration of ketamine
(Ketamin®10%, Sanofi-Ceva, Düsseldorf, Germany) and
xylazine (Xylazin 2%Bernburg, medistar, Germany). The
protocol was approved by the local Animal Use and Care
committee and the experiments were conducted in
accordance with the animal protection laws.
Induction of Adhesions
Via a midline incision, the caecum was exposed. The pari-
etal and visceral peritoneum of the ventral abdominal
wall and the caecum, respectively, were abraded within a
total area of 9 cm2. For this purpose a stamp calibrated to
a pressure of 4 kPa with an emery paper (260 grains per
cm2) mounted to a curved plate was used[22].
Experimental Groups
The animals were randomly assigned to one of four
groups. We either applied phospholipids 3.0% or normal
saline (NaCl 0,9%) (5 ml/kg body weight) to the perito-
neal cavity. In half of the rabbits of each group we simu-
lated intraperitoneal bleeding (1,5 ml blood/kg body
weight) as described below. The other half received no
additional treatment. (see table 1 + 2)
Table 1: animals/group
∅ Blood
Control (NaCl) 9 10
Phospholipids (PhL) 9 9Page 2 of 5
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mesenterial vene in a dosage of 1.5 ml per kg body weight.
The blood was dispersed in the abdominal cavity near to
the abraded areas (described above). Then the midline
incision was closed by a running suture 3-0 polyglycolic
acid.
Prior to the last stitch of abdominal closure 5 ml per kg
body weight of phospholipids (Fresenius, Germany) or
0.9% saline solution (NaCl, control group) were instilled
into the abdominal cavity. The lipid emulsion consisted
of purified egg derived phospholipids, stabilized by glyc-
erol, adjusted to physiological pH by sodium hydroxide,
and water for injection to achieve a concentration of 3.0%
(30 g phospholipids per 1000 g of emulsion). The final
product was supplied in sterile and pyrogene-free condi-
tion. Evaluation of all parameters was carried out in a
blinded fashion.
Assessment of Adhesions
After 10 days (n = 37) the animals were sacrificed by a
lethal dose of pentobarbital sodium (Narcoren®, Rhône
Merieux, Laupheim, Germany). The abdomen was
opened via a full left para-median incision for complete
exploration. Peritoneal adhesions were meticulously dis-
sected and the intestine was opened along the mesenteric
attachment for computed planimetry.
Histology
Adhesion carrying tissues (bowel, abdominal wall, omen-
tum) were excised en-bloc and fixed in formaldehyde
solution. Sections with a thickness of 5 µm were stained
with haematoxylin and eosin (HE) for light microscopy to
evaluate the structure of the connective tissue and the
healing process.
Statistical Analysis
All data are expressed as median. The Mann-Whitney U
test for independent samples was used for statistical anal-
ysis. P < 0.05 was considered statistically significant.
Results
Performance of the initial surgical procedure was unevent-
ful in all animals. Postoperatively three animals of three
different groups died of pneumonia. Therefore the follow-
ing data are based on the final examination of 37 animals.
The median (in mm2) of the adhesion area in the NaCl
group (n = 9) was 68,72 and in the NaCl+blood group
147,68.
In contrast to these results the median of adhesion area in
the PhL group was only 9,35 mm2 and in the PhL+blood
group 11,95. (see Figure 1)
The adhesion area in the NaCl group is significantly
higher compared to the PhL group (p = 0,04). Between the
blood groups again the one with added NaCl showed a
significantly higher adhesion area compared to the one
with added PhL (p = 0,017). Consequently the adhesion
area in the NaCl+blood group compared to the PhL group
is also significantly higher (p = 0,004).
No statistically significant difference was seen between the
two PhL groups (p = 0,863). (see Figure 1)
Histological analysis of representative specimens of the
injured sites revealed an inflammatory-reparative tissue
response with non-specific granulation tissue infiltrated
by mono- and polymorphonuclear cells. Activated mes-
othelial cells were found on the serosal surface as well as
subserosal fibroblastic proliferations. No differences of
the histological and cellular patterns were observed
between the control and the test groups.
Discussion
During visceral surgery damage to the mesothelial lining
is inevitable due to desiccation, thermal injury and surgi-
cal trauma. These lesions lead to oozing out of a fibrinous
median (range) of adhesion area/group (Box-and Whisker-Plot)Figure 1
median (range) of adhesion area/group (Box-and Whisker-
Plot).
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quent adhesion formation [23-25].
The refinement of surgical technique, minimizing the
peritoneal injury and avoidance of tissue ischaemia mark-
edly reduce postsurgical adhesions, but do not dissolve
them completely.
Previous studies have shown the beneficial effect of phos-
pholipids in preventing adhesion formation in a standard
visceral surgery setting in rabbits[21,22,26].
Phospholipids, polar phosphoric acid di-esters are the
natural constituents of abdominal cavity fluid and cell
membranes. Human mesothelial cells were found to rap-
idly synthesize and secrete this surfactant-like substance.
Phospholipids are zwitterions with a positive charged
quaternary ammonium ion that is able to bind to negative
charges of epithelial surfaces [27]. This fact enables small
amounts of phospholipids to cover the whole surface of
the visceral and parietal peritoneum during the healing
process of serosal defects in the surgical setting[28].
By mechanical separation of the two healing surfaces
phospholipids are able to reduce adhesion formation in
different settings[20,21].
In our study we investigated the influence of peritoneal
bleeding on adhesion formation in the presence of phos-
pholipids. Few data exist with regard to the latter.
Bioresorbable membranes like Seprafilm® or Interceed®
showed in one study a reduced effectiveness in the preven-
tion of adhesions in the presence of blood in the abdom-
inal cavity.[29,30] In the case of Interceed barrier
(oxidized regenerated cellulose) the presence of blood
abolished its effect on the prevention of coecal adhesions
and all in all the effectiveness was reduced except in neu-
tralized Interceed (nTC7)[31].
For the hyaluronan derivative gel (auto-cross-linked
polysaccharide (ACP) gel) in different preparations
(20,40,60 mg/ml) De Iaco et al. demonstrated the effec-
tiveness in postsurgical adhesion prevention even in the
presence of blood. There were no differences between the
phospholipid groups[32].
Our results are in line with our previous studies and con-
firm the efficacy of phospholipids in adhesion prevention
compared to a control group (p = 0,04).
The mean adhesion area counts to 9,35 mm2 in PhL and
11,95 mm2 in the PhL+blood group. In addition the effec-
tiveness of PhL in adhesion prevention was not reduced
by the presence of intraabdominal blood.
Conclusion
Again, these findings demonstrate the significant capabil-
ity of phospholipids to reduce adhesion formation. The
presence of intraabdominal blood does not interfere with
its efficacy.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
NB has made substantial contributions to conception and
design, acquisition of data, analysis and interpretation.
SM has made substantial contributions to conception and
design, has been involved in drafting the manuscript and
performed the statistical analysis.
KHT has been involved in drafting the conception and
revised the manuscript critically.
MA and ST have made substantial contributions to acqui-
sition of data and analysis.
APÖ and VS have made substantial contributions to con-
ception and design and read and approved the final man-
uscript.
Acknowledgements
This work was supported by a grant from Fresenius AG, Bad Homburg, 
Germany.
We thank Michael Polivoda, MD who contributed to acquisition of data.
We thank Gabriele Boehm, MD for copyediting the paper.
References
1. Beck DE, Opelka FG, Bailey HR, Rauh SM, Pashos CL: Incidence of
small-bowel obstruction and adhesiolysis after open colorec-
tal and general surgery.  Dis Colon Rectum 1999, 42(5):241-248.
2. Van der Krabben AA, Dijkstra FR, Nieuwenhuijzen M, Reijnen MM,
Schaapveld M, van Goor H: Morbidity and mortality of inadvert-
ent enterotomy during adhesiotomy.  Br J Surg 2000,
87:467-471.
3. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D,
McGuire A, Lower AM, Hawthorn RJ, O'Brien F, Buchan S, Crowe
AM: Adhesion-related hospital readmissions after abdominal
and pelvic sugery: a retrospective cohort study.  Lancet 1999,
353:1476-1480.
4. Treutner KH, Schumpelick V: Prevention of adhesions. Wish and
reality.  Chirurg 2000, 71:510-517.
5. Milamed DR, Hedley-White J: Contributions of the surgical sci-
ences to a reduction of the mortality rate in the United
States for the period 1968 to 1988.  Ann Surg 1994, 219:94-102.
6. Wilson MS, Ellis H, Menzies D, Moran BJ, Parker MC, Thompson JN:
A review of the management of small bowel obstruction.
Members of the Surgical and Clincal Adhesions Research
Study (SCAR).  Annals of the Royal College of Surgeons of England
1999, 81:320-328.
7. DeLange DCD, Jeekel J: Prevalence of adhesions and the associ-
ated costs in general surgery.  In Peritoneal Surgery: 2000; New
York Edited by: diZerega GS. New York: Springer; 2000:307-320. Page 4 of 5
(page number not for citation purposes)
BMC Surgery 2007, 7:14 http://www.biomedcentral.com/1471-2482/7/14Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
8. Ellis H: The magnitude of adhesion-related problems.  In Peri-
toneal Surgery: 2000; New York Edited by: diZerega GS. New York:
Springer; 2000:297-306. 
9. Ivarsson ML, Holmdahl L, Franzen G, Risberg B: Cost of bowel
obstruction resulting from adhesions.  Eur J Surg 1997,
163:679-684.
10. Moscowitz I, Wexner SD: Contributions of adhesions to the
cost of healthcare.  In Peritoneal Surgery: 2000; New York Edited by:
diZerega GS. New York: Springer; 2000:335-342. 
11. Ray NF, Denton WG, Thamer M, Henderson SC, Perry S: Abdomi-
nal adhesiolysis: inpatient care and expenditures in the
United States in 1994.  J Am Coll Surg 1998, 186:1-9.
12. Ray NF, Larsen JW, Stillman RJ, Jacobs RJ: Economic impact of
hospitalizations for lower abdominal adhesiolysis in the
United States in 1988.  Surg Gynecol Obstet 1993, 176:271-276.
13. Thompson J: Pathogenesis and prevention of adhesion forma-
tion.  Dig Surg 1998, 15:153-157.
14. Kowalczyk CL, Diamond MP: The management of adhesive dis-
ease.  In Peritoneal Adhesions: 1997; Berlin, Heidelberg, New York Edited
by: Treutner KH, Schumpelick V. New York: Springer; 1997:315-324. 
15. Wiseman DM: Adhesion prevention: past and future.  In Perito-
neal Surgery: 2000; New York Edited by: Gere S, di Zerega GS. New
York: Springer; 2000:401-417. 
16. Hill-West JL, Dunn RC, Hubell JA: Local release of fibrinolytic
agents for adhesion prevention.  J Surg Res 1995, 59:759-763.
17. Shear L, Swartz C, Shinaberger JA, Barry KG: Kinetics of perito-
neal fluid absorption in adult man.  N Engl J Med 1965,
272:123-127.
18. Hills BA, Burke JR, Thomas K: Surfactant barrier lining perito-
neal mesothelium: lubricant and release agent.  Perit Dial Int
1998, 18:157-165.
19. Ar'Rajab A, Ahren B, Rozga J, Bengmark S: Phosphatidylcholine
prevents postoperative peritoneal adhesions: an experimen-
tal study in rat.  J Surg Res 1991, 50:212-215.
20. Ar'Rajab A, Snoj M, Larsson K, Bengmark S: Exogenous phosphol-
ipid reduces postoperative peritoneal adhesion in rats.  Eur J
Surg 1995, 161:341-344.
21. Müller SA, Treutner KH, Tietze L, Anurov M, Titkova S, Polivoda M,
Oettinger AP, Schumpelick V: Efficacy of adhesion prevention
and impact on wound healing of intraperitoneal phospholip-
ids.  J Surg Res 2001, 96:68-74.
22. Müller SA, Treutner KH, Tietze L, Anurov M, Titkova S, Polivoda M,
Oettinger AP, Schumpelick V: Influence of intraperitoneal phos-
pholipid dosage on adhesion formation and wound healing at
different intervals after surgery.  Langenbecks Arch Surg 2001,
386:278-284.
23. Ivarsson ML, Falk P, Holmdahl L: Response of visceral perito-
neum to abdominal surgery.  Br J Surg 2001, 88:148-151.
24. Scott-Coombes D, Whawell S, Vipond MN, Thompson J: Human
intraperitoneal fibrinolytic response to elective surgery.  Br J
Surg 1995, 82:414-417.
25. Thompson J, Whawell SA: Pathogenesis and prevention of adhe-
sion formation.  Br J Surg 1995, 82:3-5.
26. Müller SA, Treutner KH, Jorn H, Anurov M, Oettinger AP,
Schumpelick V: Phospholipids reduce adhesion formation in
the rabbit uterine horn model.  Fertil Steril 2002, 77:1269-1273.
27. Hills BA: Role of surfactant in peritoneal dialysis.  Perit Dial Int
2000, 20:503-515.
28. Hills BA: Graphite-like lubrication of mesothelium by oligola-
mellar pleural surfactant.  J Appl Physiol 1992, 73:1034-1039.
29. De Cherney AH, di Zerega GS: Clincal problem of intraperito-
neal postsurgical adhesion formation following general sur-
gery and the use of adhesion prevention barriers.  Surg Clin
North Am 1997, 77(3):671-688.
30. Larsson B: Efficacy of Interceed in adhesion prevention in
gynecologic sugery: a review of 13 clinical studies.  J Reprod
Med 1996, 41:27-34.
31. Wiseman DM, Gottlick-Iarkowski L, Kamp L: Effect of different
barriers of oxidized regenerated cellulose (ORC) on cecal
and sidewall adhesions in the presence and absence of bleed-
ing.  J Invest Surg 1999, 12:141-146.
32. De Iaco PA, Muzzupapa G, Bigon E, Pressato D, Dona M, Pavesio A,
Bovicelli L: Efficacy of a hyaluron derivative gel in postsurgical
adhesion prevention in the presence of inadequate hemosta-
sis.  Surgery 2001, 130(1):60-64.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2482/7/14/prepubPage 5 of 5
(page number not for citation purposes)
